Article

Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting

2022-11-10

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objectives</h4> Prefilled syringes (PFS) may offer clinical and economic advantages to conventional parenteral medication delivery methods (vials and ampoules). The benefits of converting from vials and ampoules to PFS have been elucidated in previous drug-specific economic models; however, these models have limited generalizability to different drugs, health care settings and other countries...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d31dcb74-3fc4-5a54-87bd-3ef40f748ce8
DOI: 10.1101/2022.11.04.22281902

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital settingDOI 10.1101/2022.11.04.22281902Read

Beyond QTPP: Introducing the Quality Target Administration (QTAP) Profile for Enteral Feeding Tube MedicationsSemantic proximity Read

Maximizing Acceptance of Clinical Pharmacy Recommendations May Reduce The Length of Hospital Stay in A Private Hospital From Amman, Jordan: Toward Fully Independent Pharmacist PrescribersSemantic proximity Read

Cost of Goods Sold Analysis for Manufacturing mRNA-Based Cell and Gene TherapiesSemantic proximity Read

The intravenous formulation exposome in critical illness: a clinical pharmacology framework for fluid, electrolyte, energy and excipient exposureSemantic proximity Read

Validation and testing of the O-PALM mono-dimensional tool for evaluating the economic impact of pharmacist interventions in a Teaching HospitalSemantic proximity Read

Patients' Attitudes towards Switching to National Volume-Based Procurement (NVBP) Drugs -A Qualitative Investigation in Wuhan, ChinaSemantic proximity Read

A New Mechanism To Identify Cost Savings in NHS Prescribing: Minimising “Price-Per-Unit”Semantic proximity Read

Economic Impact of Improving Patient Safety Using Sugammadex for Routine Reversal of Neuromuscular Blockade in SpainSemantic proximity Read

Design and rationale for an empirical investigation of the resource use and costs of investigator-initiated randomized trials in Switzerland, the United Kingdom, and GermanySemantic proximity Read

Subcutaneous administration for symptom control in Primary Care: a scoping review and a nurse-led conceptual implementation roadmapSemantic proximity Read

The Net Financial Benefits of Single Vendor Integrated CDMO and CRO Drug Development ServicesSemantic proximity Read

Assessing the Value of Integrated Evidence Approaches in Drug DevelopmentSemantic proximity Read